Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 301
Filter
1.
Thyroid ; 32(7): 789-798, 2022 07.
Article in English | MEDLINE | ID: mdl-35587601

ABSTRACT

Background: Medullary thyroid cancer (MTC) is a rare malignancy originating from the calcitonin-producing C cells of the thyroid. Despite recent therapeutic advances, metastatic MTC remains incurable. Adoptive cell therapy (ACT) using genetically engineered T cells targeting either tissue-restricted tumor-associated antigens or mutated neoantigens has led to durable remissions in other metastatic solid tumors. The majority of MTC express the tumor-associated antigens calcitonin and carcinoembryonic antigen (CEA), and ∼40% of MTC harbor the RET M918T oncogenic driver mutation. Methods: We developed and characterized three immunoreceptors that recognize extracellular CEA, a calcitonin epitope presented by HLA-A*24:02, or an RET M918T neoepitope restricted by HLA-DPB1*04:01/02. The chimeric antigen receptor (CAR) targeting CEA was synthetically designed, while the T cell receptors (TCRs) targeting calcitonin and RET M918T were isolated from a transgenic mouse and patient with MTC, respectively. These immunoreceptors were genetically engineered into peripheral blood T cells and tested for antigen specificity and antitumor activity. Results: T cells expressing the anti-CEA CAR or the calcitonin-reactive TCR produced effector cytokines and displayed cytotoxicity against cell lines expressing their cognate antigen in vitro. In immunodeficient mice harboring a human MTC cell line, the adoptive transfer of T cells engineered to express the anti-CEA CAR or calcitonin-reactive TCR led to complete tumor regression. T cells expressing the HLA-DPB1*04:01/02-restricted TCR targeting RET M918T, which was cloned from peripheral blood CD4+ T cells of a patient with MTC, demonstrated specific reactivity against cells pulsed with the mutated peptide and MTC tumor cells that expressed HLA-DPB1*04:01 and RET M918T. Conclusion: The preclinical data presented herein demonstrate the potential of using genetically engineered T cells targeting CEA, calcitonin, and/or RET M918T to treat metastatic MTC.


Subject(s)
Calcitonin , Carcinoembryonic Antigen , Cell Engineering , Proto-Oncogene Proteins c-ret , Receptors, Antigen, T-Cell , T-Lymphocytes , Animals , Calcitonin/genetics , Calcitonin/immunology , Carcinoembryonic Antigen/genetics , Carcinoembryonic Antigen/immunology , Carcinoma, Neuroendocrine/drug therapy , Carcinoma, Neuroendocrine/therapy , Cell Line, Tumor , Epitopes, T-Lymphocyte/genetics , Epitopes, T-Lymphocyte/immunology , Humans , Mice , Mutation , Proto-Oncogene Proteins c-ret/genetics , Proto-Oncogene Proteins c-ret/immunology , Receptors, Antigen, T-Cell/genetics , Receptors, Antigen, T-Cell/immunology , T-Lymphocytes/immunology , Thyroid Neoplasms/genetics , Thyroid Neoplasms/metabolism , Thyroid Neoplasms/therapy
2.
Peptides ; 146: 170667, 2021 12.
Article in English | MEDLINE | ID: mdl-34600039

ABSTRACT

This work was initiated because an old publication suggested that electrocoagulation of four paraldehyde fuchsin positive cells in the brain of Locusta migratoria might produce a diuretic hormone, the identity of which remains unknown, since none of the antisera to the various putative Locusta diuretic hormones recognizes these cells. The paraldehyde fuchsin positive staining suggests a peptide with a disulfide bridge and the recently identified Locusta calcitonins have both a disulfide bridge and are structurally similar to calcitonin-like diuretic hormone. In situ hybridization and antisera raised to calcitonin-A and -B were used to show where these peptides are expressed in Locusta. Calcitonin-A is produced by neurons and neuroendocrine cells that were previously shown to be immunoreactive to an antiserum to pigment dispersing factor (PDF). The apparent PDF-immunoreactivity in these neurons and neuroendocrine cells is due to crossreactivity with the calcitonin-A precursor. As confirmed by both an PDF-precursor specific antiserum and in situ hybridisation, those calcitonin-A expressing cells do not express PDF. Calcitonin B is expressed by numerous enteroendocrine cells in the midgut as well as the midgut caeca. A guinea pig antiserum to calcitonin A seemed quite specific as it recognized only the calcitonin A expressing cells. However, rabbit antisera to calcitonin-A and-B both crossreacted with neuroendocrine cells in the brain that produce ACP (AKH/corazonin-related peptide), this is almost certainly due to the common C-terminal dipeptide SPamide that is shared between Locusta calcitonin-A, calcitonin-B and ACP.


Subject(s)
Calcitonin/metabolism , Insect Proteins/metabolism , Locusta migratoria/metabolism , Neuropeptides/metabolism , Amino Acid Sequence , Animals , Calcitonin/chemistry , Calcitonin/immunology , Guinea Pigs , Immune Sera , In Situ Hybridization , Insect Proteins/chemistry , Neuropeptides/chemistry
3.
Muscle Nerve ; 63(4): 563-567, 2021 04.
Article in English | MEDLINE | ID: mdl-33347632

ABSTRACT

INTRODUCTION: There is increasing evidence that calcitonin gene-related peptide (CGRP) plays a role in the development of neuropathic pain, a common feature of peripheral neuropathy. Although clinical studies have shown that anti-CGRP monoclonal antibodies are highly efficacious for migraine headache prophylaxis, their effects on nonheadache chronic pain conditions, including neuropathic pain, in humans are unknown. Therefore, the aim of this study was to assess the effectiveness of anti-CGRP monoclonal antibodies for neuropathic pain in patients with coexisting chronic migraine. METHODS: A retrospective chart review was conducted of 14 patients with chronic migraine and peripheral neuropathy. All patients were treated with anti-CGRP monoclonal antibodies. We collected data on patient-reported scores on the Neuropathy Pain Scale (NPS) and the frequency of migraine headache days (MHDs) per month. Data were collected 3 and 0 months before and 3, 6, 9, and 12 months after treatment with anti-CGRP medications. RESULTS: With treatment of anti-CGRP monoclonal antibodies, patients reported a 41.7% decrease in NPS scores from 89.3 at baseline to 52.1 at 12 months posttreatment (P < .05). In addition, there was a 33.3% decrease in MHDs per month from 19.8 at baseline to 13.2 at 12 months posttreatment (P < .05). DISCUSSION: Administration of anti-CGRP medications significantly improved neuropathic pain in patients who also had chronic migraine. To confirm these promising outcomes, it would be worthwhile to conduct a blinded, randomized study with a larger population of patients.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Calcitonin Gene-Related Peptide/immunology , Calcitonin/immunology , Migraine Disorders/drug therapy , Adult , Female , Humans , Male , Middle Aged , Pain Measurement/methods , Retrospective Studies
5.
Bull Exp Biol Med ; 162(6): 726-729, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28429221

ABSTRACT

We studied associations of osteocalcin, osteoprotegerin, and calcitonin with markers of inflammation in atherosclerotic plaques in coronary arteries and assessed the influence of these biomolecules on calcification of atherosclerotic plaques. The initial stage of calcification of atherosclerotic plaques is characterized by activation of inflammatory processes, which is seen from increased levels of proinflammatory biomarkers (IL-6, IL 8, TNF-α, and IL-1ß). Progressive calcification of atherosclerotic plaques is accompanied by insignificant accumulation of calcitonin and osteoprotegerin. The exception is osteocalcin, its concentration significantly increased during calcification. The results suggest that severe vascular calcification can be regarded as non-specific marker of atherosclerosis. Instability of atherosclerotic plaques is associated with higher level of calcification.


Subject(s)
Atherosclerosis/diagnosis , Calcitonin/genetics , Osteocalcin/genetics , Osteoprotegerin/genetics , Plaque, Atherosclerotic/diagnosis , Vascular Calcification/diagnosis , Aged , Atherosclerosis/complications , Atherosclerosis/genetics , Atherosclerosis/surgery , Biomarkers/metabolism , Calcitonin/immunology , Coronary Vessels/immunology , Coronary Vessels/pathology , Coronary Vessels/surgery , Endarterectomy , Gene Expression Regulation , Humans , Interleukin-1beta/genetics , Interleukin-1beta/immunology , Interleukin-6/genetics , Interleukin-6/immunology , Interleukin-8/genetics , Interleukin-8/immunology , Male , Middle Aged , Osteocalcin/immunology , Osteoprotegerin/immunology , Plaque, Atherosclerotic/complications , Plaque, Atherosclerotic/genetics , Plaque, Atherosclerotic/surgery , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/immunology , Tunica Intima/immunology , Tunica Intima/pathology , Tunica Intima/surgery , Vascular Calcification/complications , Vascular Calcification/genetics , Vascular Calcification/surgery
6.
Microb Drug Resist ; 23(4): 523-530, 2017 Jun.
Article in English | MEDLINE | ID: mdl-27754817

ABSTRACT

The severity of Pseudomonas aeruginosa (PA) infection may be determined by the interaction with the host immune system. We designed a prospective study to assess the relationship between the inflammatory response and the clinical presentation and outcome of PA infection. We also investigated whether there are differences in the inflammatory response depending on the resistance profile of PA. Interleukin-6 (IL-6), IL-10, procalcitonin (PCT), and C-reactive protein (CRP) were measured. Sixty-nine infection episodes were recorded; 40 caused by non-multidrug-resistant (non-MDR) strains [29 (73%) respiratory; 8 (20%) bacteremia], 12 by MDR non-extensively drug-resistant (MDR-non-XDR) [9 (75%) respiratory; 3 (25%) bacteremia], and 17 by XDR strains [9 (53%) respiratory; 7 (41%) bacteremia]. All inflammatory parameters were significantly higher in patients who developed acute organ dysfunction and bacteremia. PCT levels were higher in patients with early mortality [p = 0.050]. Inflammatory biomarkers were higher in patients with XDR than in those with non-MDR PA [IL-6 430 (67-951) vs. 77 (34-216), p = 0.02; IL-10 3.3 (1.5-16.3) vs. 1.3 (0-3.9), p = 0.02; and PCT 1.1 (0.6-5.2) vs. 0.3 (0.1-1.0), p = 0.008]. The intensity of inflammatory response was associated with the severity of PA infection, particularly if bacteremia occurred. Only PCT was documented useful to predict the outcome. XDR infections presented a higher inflammatory response; related in part to the larger number of bloodstream infections in this group.


Subject(s)
Bacteremia/immunology , Calcitonin/immunology , Cross Infection/immunology , Immunity, Innate , Pseudomonas Infections/immunology , Systemic Inflammatory Response Syndrome/immunology , Aged , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Bacteremia/microbiology , Bacteremia/mortality , C-Reactive Protein/genetics , C-Reactive Protein/immunology , Calcitonin/genetics , Cross Infection/drug therapy , Cross Infection/microbiology , Cross Infection/mortality , Drug Resistance, Multiple, Bacterial/physiology , Female , Gene Expression Regulation , Host-Pathogen Interactions , Humans , Interleukin-10/genetics , Interleukin-10/immunology , Interleukin-6/genetics , Interleukin-6/immunology , Male , Middle Aged , Prognosis , Prospective Studies , Pseudomonas Infections/drug therapy , Pseudomonas Infections/microbiology , Pseudomonas Infections/mortality , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/growth & development , Pseudomonas aeruginosa/pathogenicity , Signal Transduction , Survival Analysis , Systemic Inflammatory Response Syndrome/drug therapy , Systemic Inflammatory Response Syndrome/microbiology , Systemic Inflammatory Response Syndrome/mortality
7.
J Fluoresc ; 26(6): 2237-2246, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27651074

ABSTRACT

In the present study, we reported a convenient route to prepare well dispersed and functionalized K+-doped core-shell upconversion nanoparticles (UCP) by layer-by-layer (LbL) assembly of polyelectrolytes. UCP was firstly transferred to aqueous phase using cationic surfactant cetyl trimethyl ammonium bromide (CTAB) via hydrophobic interaction without removing the existing oleic acid (OA). Then the positively charged hydrophilic UCP@CTAB was further alternately deposited with negatively charged [poly (sodium 4-styrenesulfonate)] (PSS), positively charged [poly (allylamine hydrochloride)] (PAH) and negatively charged [poly (acrylic acid)] (PAA). The final carboxyl functionalized UCP@CTAB@PSS@PAH@PAA was then conjugated with monoclonal antibody1 (AB1) of procalcitonin (PCT), resulting in successful detection of PCT antigens based on the immunochromatographic assay (ICA). Linear response was achieved from 0 to 10 ng/mL, and the lowest limit of detection (LLD) was 0.18 ng/mL.


Subject(s)
Calcitonin/blood , Chromatography, Affinity/methods , Erbium/chemistry , Fluorides/chemistry , Metal Nanoparticles/chemistry , Ytterbium/chemistry , Yttrium/chemistry , Antibodies, Monoclonal/immunology , Calcitonin/immunology , Fluorescence , Humans , Limit of Detection
8.
Cell Death Dis ; 7(9): e2360, 2016 09 08.
Article in English | MEDLINE | ID: mdl-27607575

ABSTRACT

Acute respiratory distress syndrome (ARDS) is characterized by increased pulmonary inflammation and endothelial barrier permeability. Omentin has been shown to benefit obesity-related systemic vascular diseases; however, its effects on ARDS are unknown. In the present study, the level of circulating omentin in patients with ARDS was assessed to appraise its clinical significance in ARDS. Mice were subjected to systemic administration of adenoviral vector expressing omentin (Ad-omentin) and one-shot treatment of recombinant human omentin (rh-omentin) to examine omentin's effects on lipopolysaccharide (LPS)-induced ARDS. Pulmonary endothelial cells (ECs) were treated with rh-omentin to further investigate its underlying mechanism. We found that a decreased level of circulating omentin negatively correlated with white blood cells and procalcitonin in patients with ARDS. Ad-omentin protected against LPS-induced ARDS by alleviating the pulmonary inflammatory response and endothelial barrier injury in mice, accompanied by Akt/eNOS pathway activation. Treatment of pulmonary ECs with rh-omentin attenuated inflammatory response and restored adherens junctions (AJs), and cytoskeleton organization promoted endothelial barrier after LPS insult. Moreover, the omentin-mediated enhancement of EC survival and differentiation was blocked by the Akt/eNOS pathway inactivation. Therapeutic rh-omentin treatment also effectively protected against LPS-induced ARDS via the Akt/eNOS pathway. Collectively, these data indicated that omentin protects against LPS-induced ARDS by suppressing inflammation and promoting the pulmonary endothelial barrier, at least partially, through an Akt/eNOS-dependent mechanism. Therapeutic strategies aiming to restore omentin levels may be valuable for the prevention or treatment of ARDS.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Cytokines/pharmacology , Endothelial Cells/drug effects , Lectins/pharmacology , Nitric Oxide Synthase Type III/immunology , Pneumonia/drug therapy , Proto-Oncogene Proteins c-akt/immunology , Respiratory Distress Syndrome/drug therapy , Adenoviridae/genetics , Adenoviridae/metabolism , Adherens Junctions/drug effects , Adherens Junctions/metabolism , Adherens Junctions/ultrastructure , Animals , Anti-Inflammatory Agents, Non-Steroidal/immunology , Anti-Inflammatory Agents, Non-Steroidal/metabolism , Calcitonin/genetics , Calcitonin/immunology , Cell Survival/drug effects , Cytokines/genetics , Cytokines/immunology , Endothelial Cells/cytology , Endothelial Cells/metabolism , GPI-Linked Proteins/genetics , GPI-Linked Proteins/immunology , GPI-Linked Proteins/pharmacology , Gene Expression Regulation , Genetic Vectors/chemistry , Genetic Vectors/metabolism , Humans , Lectins/genetics , Lectins/immunology , Lipopolysaccharides , Lung/drug effects , Lung/immunology , Lung/pathology , Mice , Nitric Oxide Synthase Type III/genetics , Pneumonia/chemically induced , Pneumonia/immunology , Pneumonia/mortality , Primary Cell Culture , Proto-Oncogene Proteins c-akt/genetics , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Recombinant Proteins/pharmacology , Respiratory Distress Syndrome/chemically induced , Respiratory Distress Syndrome/immunology , Respiratory Distress Syndrome/mortality , Signal Transduction , Survival Analysis
9.
Immunol Invest ; 45(6): 490-503, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27224474

ABSTRACT

Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are responsible for most mortality in patients with chronic obstructive pulmonary disease (COPD) and are caused mainly by bacterial infection. We analyzed and compared neutrophil CD64 expression (using the ratio of CD64 level in neutrophils to that in lymphocytes as an index), serum C-reactive protein (CRP), procalcitonin (PCT) levels, white blood cell (WBC) count, and neutrophil percentage among healthy subjects and patients with stable COPD or AECOPD. Compared with patients with COPD and healthy subjects, patients with AECOPD demonstrated significantly increased CD64 index, CRP, PCT, WBC count, and neutrophil percentage. Interestingly, CD64 index and PCT were both significantly higher in patients with AECOPD with positive bacterial sputum culture than those with negative culture. Furthermore, CD64 index and PCT were positively correlated in AECOPD, and there was also correlation between CD64 index and CRP, WBC, and neutrophil percentage. These data suggest that CD64 index is a relevant marker of bacterial infection in AECOPD. We divided patients with AECOPD into CD64-guided group and conventional treatment group. In CD64-guided group, clinicians prescribed antibiotics based on CD64 index; while in the conventional treatment group, clinicians relied on experience and clinical symptoms to determine the necessity for antibiotics. We found that the efficacy of antibiotic treatment in CD64-guided group was significantly improved compared with the conventional treatment group, including reduction of hospital stays and cost and shortened antibiotic treatment duration. Thus, the CD64 index has important diagnostic and therapeutic implications for antibiotic treatment of patients with AECOPD.


Subject(s)
Gram-Negative Bacterial Infections/immunology , Gram-Positive Bacterial Infections/immunology , Lymphocytes/immunology , Neutrophils/immunology , Pulmonary Disease, Chronic Obstructive/immunology , Acute Disease , Aged , Anti-Bacterial Agents/economics , Anti-Bacterial Agents/therapeutic use , Biomarkers/blood , C-Reactive Protein/immunology , C-Reactive Protein/metabolism , Calcitonin/blood , Calcitonin/immunology , Case-Control Studies , Evidence-Based Medicine , Female , Gram-Negative Bacterial Infections/complications , Gram-Negative Bacterial Infections/drug therapy , Gram-Negative Bacterial Infections/microbiology , Gram-Positive Bacterial Infections/complications , Gram-Positive Bacterial Infections/drug therapy , Gram-Positive Bacterial Infections/microbiology , Humans , Length of Stay/economics , Leukocyte Count , Lymphocytes/drug effects , Lymphocytes/microbiology , Lymphocytes/pathology , Male , Middle Aged , Neutrophils/drug effects , Neutrophils/microbiology , Neutrophils/pathology , Pulmonary Disease, Chronic Obstructive/complications , Pulmonary Disease, Chronic Obstructive/drug therapy , Pulmonary Disease, Chronic Obstructive/microbiology , Receptors, IgG/blood , Receptors, IgG/immunology
11.
J Nanobiotechnology ; 13: 33, 2015 May 06.
Article in English | MEDLINE | ID: mdl-25944262

ABSTRACT

BACKGROUND: Nanobodies (Nbs) are single-domain antigen-binding fragments derived from the camelids heavy-chain only antibodies (HCAbs). Their unique advantageous properties make Nbs highly attractive in various applications. The general approach to obtain Nbs is to isolate them from immune libraries by phage display technology. However, it is unfeasible when the antigens are toxic, lethal, transmissible or of low immunogenicity. Naïve libraries could be an alternative way to solve the above problems. RESULTS: We constructed a large camel naïve phage display Nanobody (Nb) library with great diversity. The generated library contains to 6.86 × 10(11) clones and to our best of knowledge, this is the biggest naïve phage display Nb library. Then Nbs against human procalcitonin (PCT) were isolated from this library. These Nbs showed comparable affinity and antigen-binding thermostability at 37°C and 60°C compared to the PCT Nbs from an immune phage-displayed library. Furthermore, two PCT Nbs that recognize unique epitopes on PCT have been successfully applied to develop a sandwich enzyme-linked immunosorbent assay (ELISA) to detect PCT, which showed a linear working range from 10-1000 ng/mL of PCT. CONCLUSION: We have constructed a large and diverse naïve phage display Nb library, which potentially functioning as a good resource for selecting antigen-binders with high quality. Moreover, functional Nbs against PCT were successfully characterized and applied, providing great values on medical application.


Subject(s)
Calcitonin/immunology , Peptide Library , Protein Precursors/immunology , Single-Domain Antibodies/pharmacology , Amino Acid Sequence , Animals , Biotinylation , Calcitonin Gene-Related Peptide , Camelus/immunology , Enzyme-Linked Immunosorbent Assay , Epitopes/metabolism , Escherichia coli/genetics , Humans , Lymphocytes/immunology , Molecular Sequence Data , Single-Domain Antibodies/isolation & purification , Single-Domain Antibodies/metabolism
12.
Clin Chim Acta ; 444: 37-42, 2015 Apr 15.
Article in English | MEDLINE | ID: mdl-25659293

ABSTRACT

BACKGROUND: Procalcitonin (PCT) has been recognized as a biomarker in severe inflammation, infection and sepsis. PCT detection in serum requires sensitive and specific antibodies. In this study, we generated monoclonal antibodies (mAbs) and developed fluorescent immunochromatographic assay for PCT detection. METHODS: Human recombinant PCT was used as immunogen. mAbs against PCT were developed and applied to fluorescent immunochromatographic assay for PCT detection in clinical samples. RESULTS: Out of 35 hybridoma cell lines secreting antibodies against the recombinant PCT, five sensitive and specific cell lines were selected and designated as F6, G2, C2, D2 and E5. All these antibodies have no cross reaction with calcitonin or calcitonin gene-related peptides (CGRP). After screening for pairing, mAb F6 was labeled with fluorescent microspheres and C2 was coated on a nitrocellulose membrane for immunochromatographic test. All 35 clinical samples were detected by the mAb F6-C2 test strips and the bioMérieux PCT assay. The test strips showed high specificity and sensitivity for PCT. Good correlation was observed between our immunochromatographic test strips and the bioMérieux PCT assay (R(2):0.986). CONCLUSIONS: These newly developed anti-PCT mAbs and fluorescent immunochromatographic assay can serve as important diagnostic tools for a fast, reliable and point-of-care testing for easy determination of PCT in serum and diagnosis of bacterial infection, inflammation or sepsis.


Subject(s)
Calcitonin/blood , Chromatography, Affinity/methods , Fluorescence , Protein Precursors/blood , Animals , Antibodies, Monoclonal/immunology , Antigen-Antibody Reactions , Calcitonin/genetics , Calcitonin/immunology , Calcitonin Gene-Related Peptide , China , Enzyme-Linked Immunosorbent Assay , Female , Humans , Mice , Mice, Inbred BALB C , Protein Precursors/genetics , Protein Precursors/immunology , Recombinant Proteins/blood , Recombinant Proteins/genetics , Recombinant Proteins/immunology
13.
J Crit Care ; 30(2): 282-9, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25617260

ABSTRACT

OBJECTIVE: The objective of this study is to evaluate the benefits of adjuvant treatment with crude rhubarb in patients with systemic inflammation reaction syndrome/sepsis by conducting a meta-analysis. METHODS: We conducted a systematic literature search of medical electronic databases (up to October 2013). Only randomized controlled trials (RCTs) assessing adjuvant treatment with crude rhubarb in septic patients were included. RESULTS: A total of 15 RCTs with 869 patients were identified. Pooled analysis showed that interleukin 6 (standardized mean differences [SMDs], -1.30; 95% confidence intervals [CIs], -1.94 to -0.66), tumor necrosis factor α (SMD, -0.95; 95% CI, -1.55 to -0.36), procalcitonin (SMD, -1.50; 95% CI, -2.20 to -0.80), von Willebrand factor (mean differences [MDs], -144.11; 95% CI, -253.87 to -34.35), prothrombin time (MD, -2.38; 95% CI, -2.67 to -2.10), acute physiology and chronic health evaluation II scores (MD, -4.51; 95% CI, -5.30 to -3.73), and gastrointestinal dysfunction (risk ratio, 0.28; 95% CI, 0.16-0.49) were significantly reduced after treatment with crude rhubarb. Platelet number (MD, 58.16; 95% CI, 51.16-65.15) was significantly increased. However, crude rhubarb therapy did not significantly reduce 28-day mortality (risk ratio, 0.60; 95% CI, 0.36-1.00) compared with the usual treatment. CONCLUSIONS: Adjuvant treatment with crude rhubarb appears to have additional benefits in septic patients. Antiinflammation and anticoagulant/antiaggregant properties may be its potential mechanism.


Subject(s)
Phytotherapy , Rheum , Sepsis/drug therapy , Systemic Inflammatory Response Syndrome/drug therapy , Adolescent , Adult , Aged , Aged, 80 and over , Calcitonin/immunology , Calcitonin Gene-Related Peptide , Female , Humans , Inflammation , Interleukin-6/immunology , Male , Middle Aged , Protein Precursors/immunology , Randomized Controlled Trials as Topic , Sepsis/immunology , Systemic Inflammatory Response Syndrome/immunology , Treatment Outcome , Tumor Necrosis Factor-alpha/immunology , Young Adult
14.
Methods Mol Biol ; 1237: 213-24, 2015.
Article in English | MEDLINE | ID: mdl-25319789

ABSTRACT

Procalcitonin is the prohormone of calcitonin and present in minute quantities in health. However, during infection, its levels rise considerably and are correlated with the severity of the infection. Several assays have been developed for measurement of procalcitonin levels; in this article, we will briefly present the PCT-sensitive Kryptor(®) test (Brahms, Hennigsdorf, Germany), one of the most widely used assays for procalcitonin in recent studies. Many studies have demonstrated the value of procalcitonin levels for diagnosing sepsis and assessing disease severity. Procalcitonin levels have also been successfully used to guide antibiotic administration. However, procalcitonin is not specific for sepsis, and values need to be interpreted in the context of a full clinical examination and the presence of other signs and symptoms of sepsis.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacterial Infections/diagnosis , Bacterial Infections/drug therapy , Calcitonin/blood , Protein Precursors/blood , Sepsis/diagnosis , Sepsis/drug therapy , Bacterial Infections/immunology , Bacterial Infections/microbiology , Biomarkers/blood , Calcitonin/immunology , Calcitonin Gene-Related Peptide , Drug Monitoring , Energy Transfer , Humans , Immunoassay , Protein Precursors/immunology , Sensitivity and Specificity , Sepsis/immunology , Sepsis/microbiology , Severity of Illness Index , Spectrometry, Fluorescence
15.
Methods Mol Biol ; 1237: 247-60, 2015.
Article in English | MEDLINE | ID: mdl-25319792

ABSTRACT

Sepsis is among the most common causes of death in hospitalized patients, and early recognition followed by immediate initiation of therapy is an important concept to improve survival in these patients. According to the definition of sepsis, diagnosis of sepsis requires the recognition of the systemic inflammatory response syndrome (SIRS) caused by infection as well as recognition of possible infection-related organ dysfunctions for diagnosis of severe sepsis or septic shock. Both SIRS and organ dysfunctions may occur frequently in hospitalized patients for various reasons. However, the fast recognition of acute infection as a cause of SIRS and newly developed organ dysfunction may be a demanding task since culture-based results of microbiological samples will be available only days after onset of symptoms. Biomarkers and PCR-based pathogen detection may help the physician in differentiating SIRS from sepsis. Procalcitonin (PCT) is the best investigated biomarker for this purpose. Furthermore, the current data support the usage of PCT for guidance of antimicrobial therapy. C-reactive protein (CRP) may be used to monitor the course of infection but has only limited discriminative capabilities. Interleukin-6 is widely used for its fast response to the infectious stimulus, but conclusive data for the application of this biomarker are missing. None of the available biomarkers can by itself reliably differentiate SIRS from sepsis but can aid and shorten the decision process. PCR-based pathogen detection can theoretically shorten the recognition of the underlying pathogen to about 8 h. However, this technique is expensive and requires additional staff in the laboratory; controlled prospective studies are missing. Although current studies suggest that PCR-based pathogen detection may be useful to shorten time to adequate antimicrobial therapy and diagnose invasive Candida infections, no general recommendations about the application of PCR for the diagnosis of sepsis can be given.


Subject(s)
Calcitonin/blood , Gram-Positive Bacterial Infections/diagnosis , Molecular Diagnostic Techniques , Protein Precursors/blood , Shock, Septic/diagnosis , Biomarkers/blood , C-Reactive Protein/immunology , C-Reactive Protein/metabolism , Calcitonin/immunology , Calcitonin Gene-Related Peptide , Gram-Positive Bacterial Infections/immunology , Gram-Positive Bacterial Infections/microbiology , Gram-Positive Bacterial Infections/pathology , Humans , Immunoassay , Interleukin-6/blood , Interleukin-6/immunology , Male , Middle Aged , Polymerase Chain Reaction , Protein Precursors/immunology , Severity of Illness Index , Shock, Septic/immunology , Shock, Septic/microbiology , Shock, Septic/pathology
16.
Am J Pathol ; 184(11): 3069-83, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25251058

ABSTRACT

Acute lung injury (ALI) secondary to sepsis is a complex syndrome associated with high morbidity and mortality. We report that aminoprocalcitonin (NPCT), an endogenous peptide derived from the prohormone procalcitonin, plays a critical role in the development of ALI during severe sepsis and is a suggested risk factor for sepsis morbidity and mortality. Lethal sepsis was induced in rats by cecal ligation and puncture (CLP). Two hours after CLP, an i.p. injection of 200 µg/kg of anti-rat NPCT antibody was followed by continuous infusion of anti-NPCT (16 µg per hour) via a minipump for 18 hours. Samples were harvested 20 hours after CLP. High expressions of the CALCA gene, procalcitonin, and NPCT were detected in the lung tissue of rats with severe sepsis. Immunoneutralization of NPCT decreased pulmonary levels of CALCA, procalcitonin, and NPCT; reduced lung inflammation and injury, neutrophil infiltration, and bacterial invasion; and improved survival in sepsis. Anti-NPCT treatment also suppressed sepsis-induced inflammatory cytokine expression, cytoplasmic degradation of the inhibitor of NF-κB, IκBα, and nuclear NF-κB translocation in lung tissues. Therapeutic benefits of anti-NPCT were also associated with increased pulmonary levels of the anti-inflammatory cytokine IL-10. These data support a pathogenic role for NPCT in sepsis and suggest NPCT as a potential new target for clinical prevention and treatment of ALI in severe sepsis.


Subject(s)
Acute Lung Injury/drug therapy , Antibodies, Neutralizing/therapeutic use , Calcitonin/immunology , Protein Precursors/immunology , Sepsis/complications , Acute Lung Injury/etiology , Acute Lung Injury/immunology , Acute Lung Injury/metabolism , Animals , Calcitonin/metabolism , Calcitonin Gene-Related Peptide , Disease Models, Animal , Interleukin-10/metabolism , Male , NF-kappa B/metabolism , Protein Precursors/metabolism , Rats , Rats, Wistar , Sepsis/metabolism , Tumor Necrosis Factor-alpha/metabolism
18.
Microbiol Immunol ; 58(3): 172-9, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24438185

ABSTRACT

Several optical imaging techniques have been used to monitor bacterial tropisms for cancer. Most such techniques require genetic engineering of the bacteria to express optical reporter genes. This study investigated a novel tumor-targeting strain of bacteria, Rhodobacter sphaeroides 2.4.1 (R. sphaeroides), which naturally emits near-infrared fluorescence, thereby facilitating the visualization of bacterial tropisms for cancer. To determine the penetration depth of bacterial fluorescence, various numbers of cells (from 10(8) to 10(10) CFU) of R. sphaeroides and two types of Escherichia coli, which stably express green fluorescent protein (GFP) or red fluorescent protein (RFP), were injected s.c. or i.m. into mice. Bacterial tropism for cancer was determined after i.v. injection of R. sphaeroides (10(8) CFU) into mice implanted s.c. with eight types of tumors. The intensity of the fluorescence signal in deep tissue (muscle) from R. sphaeroides was much stronger than from E. coli-expressing GFP or RFP. The near-infrared fluorescence signal from R. sphaeroides was visualized clearly in all types of human or murine tumors via accumulation of bacteria. Analyses of C-reactive protein and procalcitonin concentrations and body weights indicated that i.v. injection of R. sphaeroides does not induce serious systemic immune reactions. This study suggests that R. sphaeroides could be used as a tumor-targeting microorganism for the selective delivery of drugs to tumor tissues without eliciting a systemic immune reaction and for visualizing tumors.


Subject(s)
Drug Delivery Systems/methods , Neoplasms/pathology , Neoplasms/therapy , Rhodobacter sphaeroides , Animals , C-Reactive Protein/immunology , Calcitonin/immunology , Calcitonin Gene-Related Peptide , Fluorescence , HeLa Cells , Humans , Infrared Rays , Male , Mice , Mice, Inbred BALB C , Mice, Nude , Neoplasms/immunology , Protein Precursors/immunology
19.
J Surg Res ; 187(1): 237-43, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24239146

ABSTRACT

BACKGROUND: The objective of this study was to determine the diagnostic value of neutrophil gelatinase-associated lipocalin (NGAL), C-reactive protein (CRP), and procalcitonin (PCT) in the prognosis of patients presenting with the systemic inflammatory response syndrome (SIRS) with nephrolithiasis. METHODS: Urine NGAL protein levels were measured by enzyme-linked immunosorbent assay in 87 patients presenting with nephrolithiasis who were diagnosed as SIRS. Additionally, 52 patients presenting with nephrolithiasis but without urinary tract infection and 30 healthy controls were also included in the study. Levels of serum CRP and PCT were also taken into consideration. RESULTS: Median urinary NGAL levels were significantly increased in the SIRS cohorts compared with nephrolithiasis without urinary tract infection patients (4.28 ng/mL versus 2.69 ng/mL, P < 0.001), and NGAL was markedly elevated even in the early stage of SIRS (3.23 ng/mL versus 2.69 ng/mL, P < 0.001). According to the receiver-operating characteristic analysis, NGAL demonstrated a high diagnostic value compared with either PCT or CRP. In the later stage of SIRS, NGAL remained a highly sensitive (76.8%) and specific (86.5%) diagnostic marker compared with either PCT or CRP. Moreover, the area under the curves of NGAL (0.822) were also superior to those seen in either PCT (0.657) or CRP (0.761). CONCLUSION: Urinary NGAL is a highly sensitive and specific predictor of SIRS for patients presenting with nephrolithiasis. Further study of NGAL as a reliable biomarker of SIRS is required.


Subject(s)
Acute-Phase Proteins/urine , Lipocalins/urine , Nephrolithiasis/diagnosis , Proto-Oncogene Proteins/urine , Systemic Inflammatory Response Syndrome/diagnosis , Acute-Phase Proteins/immunology , Adult , Biomarkers/urine , C-Reactive Protein/immunology , C-Reactive Protein/metabolism , Calcitonin/blood , Calcitonin/immunology , Calcitonin Gene-Related Peptide , Female , Humans , Lipocalin-2 , Lipocalins/immunology , Male , Nephrolithiasis/immunology , Nephrolithiasis/metabolism , Prognosis , Protein Precursors/blood , Protein Precursors/immunology , Proto-Oncogene Proteins/immunology , ROC Curve , Sensitivity and Specificity , Systemic Inflammatory Response Syndrome/immunology , Systemic Inflammatory Response Syndrome/metabolism , Young Adult
20.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi ; 29(5): 504-6, 2013 May.
Article in Chinese | MEDLINE | ID: mdl-23643271

ABSTRACT

OBJECTIVE: To clone, express the procalcitonin (PCT) and prepare its polyclonal antibody. METHODS: We designed 10 DNA primers according to the encoding sequence of human PCT gene from GenBank, amplified PCT gene by PCR and constructed the recombinant vector pGEX-KG-PCT. Then the fusion protein, PCT-GST, was expressed in E.coli and purified by affinity chromatography. The corresponding polyclonal antibody was produced in the New Zealand white rabbits immunized with the fusion protein, and its biological activity was detected by Western blotting. The specificity and titer of the polyclonal antibody was identified by agar gel immunodiffusion test. RESULTS: We successfully obtained the full-length PCT gene and expressed the fusion PCT-GST in E.coli. SDS-PAGE showed that relative molecular mass (Mr;) was about 36 000. Agar gel immunodiffusion test revealed that the prepared polyclonal antibody could specially recognized PCT and its titer was 1:4. CONCLUSION: The PCT is successfully cloned, expressed and purified. The high specific polyclonal antibody of PCT is prepared.


Subject(s)
Antibodies/immunology , Antibodies/isolation & purification , Calcitonin/genetics , Calcitonin/immunology , Cloning, Molecular , Gene Expression , Protein Precursors/genetics , Protein Precursors/immunology , Animals , Antibody Specificity/immunology , Calcitonin Gene-Related Peptide , Humans , Plasmids/genetics , Polymerase Chain Reaction , Rabbits , Recombinant Fusion Proteins
SELECTION OF CITATIONS
SEARCH DETAIL